Neoplasms - Epidemiology
Research News and Information

Saturday, November 21, 2009

Cancer risk evaluation in psoriasis: in search of the Holy Grail?

30 Oct 2009 Benefit-risk assessment of systemic treatment in psoriasis is a dynamic process. Long-term safety of psoriasis therapies has been questioned, with the spectrum of systemic immunosuppression potentially leading to increased cancer risk. In this ... Read more...

Prevalence and predictors of abandonment of therapy among children with cancer in El Salvador.

30 Oct 2009 Abandonment of therapy is one of the most common causes of treatment failure among children with cancer in low-income countries. Our objectives were to describe the prevalence and predictors of abandonment among such children with cancer in El ... Read more...

Patterns of hematologic malignancies and solid tumors among 37,838 first-degree relatives of 13,896 patients with multiple myeloma in Sweden.

30 Oct 2009 There are emerging data to suggest a role for genetic factors in the pathogenesis of multiple myeloma (MM). Based on small numbers, certain solid tumors have been reported to occur more frequently among blood relatives of patients with MM. Using ... Read more...

Latest indexed articles for 'Neoplasms - Epidemiology'

These are the very latest articles for this heading:

• Cancer risk evaluation in psoriasis: in search of the Holy Grail? 30 Oct 2009
• Increase of wildlife cancer: an echo of plastic pollution? 30 Oct 2009
• Prevalence and predictors of abandonment of therapy among children with cancer in El Salvador. 30 Oct 2009
• Patterns of hematologic malignancies and solid tumors among 37,838 first-degree relatives of 13,896 patients with multiple myeloma in Sweden. 30 Oct 2009
• Metabolic regulation and redox activity as mechanisms for angioprevention by dietary phytochemicals. 30 Oct 2009
• Cancer incidence in Israeli Jewish survivors of World War II. 24 Oct 2009
• Cancer risk from extreme stressors: lessons from European Jewish survivors of World War II. 24 Oct 2009
• Cancer incidence and risk factors after solid organ transplantation. 13 Oct 2009
• Role of uncontrolled HIV RNA level and immunodeficiency in the occurrence of malignancy in HIV-infected patients during the combination antiretroviral therapy era: Agence Nationale de Recherche sur le Sida (ANRS) CO3 Aquitaine Cohort. 29 Sep 2009
• Uncontrolled HIV RNA, immunodeficiency, and malignancy: implications for cancer control. 29 Sep 2009
• Reproductive outcomes in male childhood cancer survivors: a linked cancer-birth registry analysis. 29 Sep 2009
• Pregnancy outcomes in female childhood and adolescent cancer survivors: a linked cancer-birth registry analysis. 29 Sep 2009
• The search for infectious causes of human cancers: where and why. 13 Sep 2009
• Catheter-associated thrombosis in patients with malignancy. 6 Sep 2009
• Anxiety and depression among long-term survivors of cancer in Australia: results of a population-based survey. Comment. 5 Sep 2009
• Anxiety and depression among long-term survivors of cancer in Australia: results of a population-based survey. 5 Sep 2009
• Weighing benefits and risks--the FDA's review of prasugrel. Sep 2009
• [Radiation therapy in elderly patients] 31 Aug 2009
• [Could serum DHEA and DHEAS levels be good risk predictors of metabolic syndrome and osteoporosis in the population of ageing men?] 30 Aug 2009
• Lipid-lowering drugs and risk for cancer. 30 Aug 2009

See a longer list of these articles.

Technical information about 'Neoplasms'

Definition: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.

Descriptor UI: D009369

Alternative terms: Neoplasms; Neoplasm; Tumors; Tumor; Benign Neoplasms; Neoplasms, Benign; Benign Neoplasm; Neoplasm, Benign; Cancer; Cancers;

Related Mesh Headings: Antibodies, Neoplasm; Antigens, Neoplasm; Antineoplastic Agents; Carcinogens; DNA, Neoplasm; Oncogenic Viruses; Precancerous Conditions; RNA, Neoplasm; Pleural Effusion, Malignant; Genes, Tumor Suppressor; Anticarcinogenic Agents;

Allowable Qualifiers: blood; blood supply; cerebrospinal fluid; chemically induced; classification; complications; congenital; diagnosis; diet therapy; drug therapy; economics; embryology; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; radiotherapy; rehabilitation; secretion; surgery; therapy; ultrastructure; urine; veterinary; ultrasonography; chemistry; virology;

Tree Number: C04;

Online Note: pre-explosion = NEOPLASMS (PX)

History Note: /diagnosis was NEOPLASM DIAGNOSIS 1964-65; /etiology was NEOPLASM ETIOLOGY 1964-65; /immunology was NEOPLASM IMMUNOLOGY 1964-65; /radiotherapy was NEOPLASM RADIOTHERAPY 1964-65; /therapy was NEOPLASM THERAPY 1964-65; NEOPLASM STATISTICS was heading 1964-65; CARCINOGENESIS was heading 1977

Technical Notes: avoid: too general; prefer specifics; policy: Manual section 24; /chem ind permitted but consider also CARCINOGENS; /class: consider also NEOPLASM STAGING (see note there) but "grading" = /pathol; /etiol: consider also ONCOGENIC VIRUSES; /vet: Manual 24.6+ or TN 136; TN 135: MeSH terms for neoplasms classed by tissue; /drug ther: consider also ANTINEOPLASTIC AGENTS & its specifics; /genet: consider also GENES, TUMOR SUPPRESSOR /immunol: consider also TUMOR ESCAPE; consider also ANTIGENS, NEOPLASM & ANTIBODIES, NEOPLASM; /microbiol: consider also ONCOGENIC VIRUSES; /nurs = the patient, ONCOLOGIC NURSING = the oncologic specialty; /prev: consider also ANTICARCINOGENIC AGENTS; /radiother = the patient, RADIATION ONCOLOGY = the specialty; consider also BRACHYTHERAPY; /second = NEOPLASM METASTASIS but do not confuse with NEOPLASMS, SECOND PRIMARY; familial: consider also NEOPLASTIC SYNDROMES, HEREDITARY; metastatic cancer of unknown origin: index under NEOPLASM METASTASIS; Tumor Key: TN Suppl